Intellectual Property India Publishes Patent Application for 'Dpp1 Inhibitors With Polycyclic Linkers And Uses Thereof' Filed by Insmed Incorporated

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517099307 A) filed by Insmed Incorporated, Bridgewater, U.S.A., on Oct. 14, for 'dpp1 inhibitors with polycyclic linkers and uses thereof.'

Inventor(s) include Plaunt, Adam J.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts or deuterated forms thereof, wherein R0, L and R1 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt or deuterated form thereof, and methods of using a compound of Formula (I) or pharmaceutically acceptable salt or deuterated form thereof, e.g., in the treatment of a disease that is treatable by administration of a DPP1 inhibitor."

The patent application was internationally filed on Mar. 15, 2024, under International application No.PCT/US2024/020305.

Disclaimer: Curated by HT Syndication.